Penn Medicine Press Release
Media Inquiries contact:
Office: (215) 349-5659
Cell: (215) 200-2313
Penn Study: Slowly Progressive Weight-Training Program Reduces Chances of Increased Arm Swelling By As Much as 70 Percent
Weightlifting may play a key role in a program to prevent the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team’s previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment. The research results will be presented today at the San Antonio Breast Cancer Symposium and published online concurrently in the Journal of the American Medical Association.
“Lymphedema is a dreaded, common side effect of breast cancer treatment. Women worry that they will recover from their cancer only to be plagued by this condition that often limits their ability to work, maintain their homes, and care for their children or grandchildren,” says lead author Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of Penn's Abramson Cancer Center. “Our study shows that they now have a weapon to reduce their risk of arm swelling, and at the same time, reap the many other health rewards of weightlifting that they have missed out on due to decades of advice to avoid lifting so much as a grocery bag or their purse.” Read More
Editor’s note: Multimedia content about this study, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links are available at www.digitalnewsrelease.com/?q=jama_3770.
Resources for patients and fitness trainers are available here.
Dr. Schmitz hosted a live web chat for patients, fitness trainers and clinicians on www.oncolink.org on Thursday, Dec. 9. View transcripts here.